WASHINGTON--(BUSINESS WIRE)--Jan. 4, 2005--Allied Capital Corporation (NYSE:ALD) announced it completed the buyout of Insight Pharmaceuticals Corporation on December 31, 2004. Allied Capital’s investment in Insight Pharmaceuticals totals approximately $155 million, including debt securities and all of the outstanding stock of the company. Additionally, Allied Capital has committed approximately $5 million in financing that can be drawn upon by the company. Insight Pharmaceuticals is a leading marketer and distributor of well-known, over-the-counter pharmaceutical products. The company’s portfolio consists of 20 diverse brands that provide relief from cough/cold, pain, allergy, and other common ailments. The products are sold through an extensive network of drug, mass, food, dollar, and convenience stores and wholesalers.
